NanoPalm | نانو بالم

NanoPalm is a cutting-edge DeepTech company focused on revolutionizing in-vivo gene therapies for genetic diseases. NanoPalm employs an advanced Lipid Nanoparticle (LNP) manufacturing process to create stable LNPs that can self-target specific organs and cells, overcoming the limitations of current LNP-based therapies. Located in Riyadh, SA (Primary address), NanoPalm is dedicated to pioneering the next generation of nanomedicine.

NanoPalm is committed to advancing biotechnology research to develop innovative solutions for challenging medical conditions. With a focus on precision and efficacy, NanoPalm strives to improve patient outcomes through targeted gene therapies. The company’s commitment to excellence drives its research and development efforts, ensuring the highest standards of quality and performance.

NanoPalm continues to expand its capabilities and impact within the biotechnology sector. We invite NanoPalm's management to create a customized and exclusive company showcase and product listing on our platform, to highlight their ground-breaking work in nanomedicine and biotechnology research.